GoodCap Pharmaceuticals Inc. Patents

Patent portfolio assigned to GoodCap Pharmaceuticals Inc. (verified via public assignee records). Estimated patent count: 1. Calgary-based psychedelics (low-dose psilocybin) drug developer. Published intl patent application WO2022079574A1 / PCT/IB2021/059301 'Compositions for Reducing Inflammation' (assignee Goodcap Pharmaceuticals Ltd). No named competitors or customers sourceable (early-stage drug developer).